Opthea Ltd (CKDXF) stock
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea cash
Cash and short-term investments held at the end of each period.
Opthea's cash was $48.44M at Jun 30, 2025. For fiscal 2025 it was $48.44M, down 71.9% from the year before. The highest annual figure on record is $172.47M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $48.44M | -71.9% |
| FY2024 | Jun 30, 2024 | $172.47M | +93.4% |
| FY2023 | Jun 30, 2023 | $89.19M | +99.8% |
| FY2022 | Jun 30, 2022 | $44.63M | -62.2% |
| FY2021 | Jun 30, 2021 | $118.19M | +177.1% |
| FY2020 | Jun 30, 2020 | $42.65M | +182.0% |
| FY2019 | Jun 30, 2019 | $15.12M | -37.2% |
| FY2018 | Jun 30, 2018 | $24.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $48.44M | -45.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $172.47M | +45.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $89.19M | -42.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $44.63M | +4.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $88.27M | +483.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $118.19M | +390.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $156.13M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $42.65M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $15.12M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $24.08M | – |
See a number that looks wrong?